STOK Stoke Therapeutics, Inc. - Common Stock
$29,99
Prix · Mai 20, 2026
Données fondamentales au Mai 7, 2026
Fourchette 52 semaines
$9–$40
67% of range
Note des analystes
BUY
18 analysts
Objectif de cours
$45
+50% upside
P/E (TTM)
-264.5
ROE
-2.0%
Marge nette
-3.7%
STOK Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$29.99
Capitalisation Boursière
$1.87B
P/E (TTM)
-264.5
BPA (TTM)
$-0.12
Revenus (TTM)
$184M
Rendement div.
—
ROE
-2.0%
Dette/Capitaux propres
—
Fourchette 52 semaines
$9 – $40
STOK Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$184M
2022-12-31
→
2025-12-31
BPA
$-0.12
2021-12-31
→
2025-12-31
Flux de trésorerie libre
$45M
2019-12-31
→
2025-12-31
Marges
-3.7%
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
STOK
Médiane des pairs
P/E (TTM)
-264.5
11.3
P/S (TTM)
10.1
22.0
P/B
5.3
6.3
Price / FCF (Cours / FCF)
41.6
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
STOK
Médiane des pairs
Operating Margin (Marge d'exploitation)
-11.2%
—
Net Profit Margin (Marge nette)
-3.7%
-74.2%
ROA
-2.0%
-30.3%
ROE
-2.0%
-42.3%
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
STOK
Médiane des pairs
Current Ratio (Ratio de liquidité)
5.3
8.0
Quick Ratio (Ratio de liquidité réduite)
1.6
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
STOK
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
404.5%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
145.9%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
STOK
Médiane des pairs
STOK Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
18 analystes
- Achat fort 8 44,4%
- Achat 9 50,0%
- Conserver 1 5,6%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
10 analystes · 2026-05-16
Médiane
$40.00
Moyenne
$45.10
← En dessous de tous les objectifs
$29.99
Bas
$35.00
Haut
$60.00
Objectif médian
$40.00
+33,4%
Objectif moyen
$45.10
+50,4%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.44%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-0.79 | $-0.84 | 0.05% |
| 31 décembre 2025 | $-0.97 | $-0.73 | -0.24% |
| 30 septembre 2025 | $-0.65 | $-0.58 | -0.07% |
| 30 juin 2025 | $-0.40 | $-0.52 | 0.12% |
| 31 mars 2025 | $1.98 | $-0.43 | 2.4% |
| 31 décembre 2024 | $-0.18 | $-0.54 | 0.36% |
Comparaison avec les pairs Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| STOK | $1.87B | -264.5 | 404.5% | -3.7% | -2.0% | — |
| BCRX | $1.66B | 6.4 | 94.1% | 30.2% | -97.6% | — |
| TYRA | $1.41B | -13.1 | — | — | -42.7% | — |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| SRPT | $2.26B | -3.0 | 15.6% | -32.5% | -57.1% | — |
| ZYME | $1.97B | -24.4 | 38.9% | -76.6% | -26.9% | — |
| SNDX | $1.84B | -6.4 | 627.8% | -165.6% | -257.1% | — |
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | — |
| VCEL | $1.82B | 112.5 | 16.4% | 6.0% | 5.0% | 74.4% |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 15
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $184M | $37M | $9M | $12M | |
| R&D Expense | $138M | $89M | $82M | $78M | |
| SG&A Expense | $67M | $49M | $41M | $39M | |
| Operating Expenses | $205M | $138M | $124M | $117M | |
| Operating Income | $-21M | $-101M | $-115M | $-104M | |
| Interest Expense | $9.0K | $26.0K | $49.0K | · | |
| Interest Income | $14M | $13M | $10M | · | |
| Other Non-op | $-51.0K | $-247.0K | $166.0K | $167.0K | |
| Income Tax | $0 | · | · | · | |
| Net Income | $-7M | $-89M | $-105M | $-101M | |
| EPS (Basic) | $-0.12 | $-1.65 | $-2.38 | $-2.60 | |
| EPS (Diluted) | $-0.12 | $-1.65 | $-2.38 | $-2.60 | |
| Shares (Basic) | 59,219,184 | 54,008,883 | 43,994,862 | 38,897,442 | |
| Shares (Diluted) | 59,219,184 | 54,008,883 | 43,994,862 | 38,897,442 | |
| EBITDA | $-21M | $-101M | $-115M | $-104M |
Bilan 21
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $84M | $128M | $191M | $114M | |
| Receivables | $6M | $2M | · | · | |
| Prepaid Expense | $9M | $11M | $11M | $11M | |
| Other Current Assets | $4M | $2M | $3M | $3M | |
| Current Assets | $306M | $233M | $215M | $244M | |
| PP&E (Net) | $3M | $4M | $6M | $7M | |
| PP&E (Gross) | $13M | $13M | $12M | $11M | |
| Accum. Depreciation | $10M | $9M | $7M | $4M | |
| Total Assets | $418M | $272M | $228M | $256M | |
| Accounts Payable | $5M | $2M | $2M | $766.0K | |
| Current Liabilities | $58M | $40M | $31M | $31M | |
| Capital Leases | $1M | $2M | $5M | $3M | |
| Other Non-current Liabilities | $1M | $2M | $5M | $3M | |
| Total Liabilities | $66M | $43M | $69M | $71M | |
| Common Stock | $5.0K | $5.0K | $5.0K | $4.0K | |
| Paid-in Capital | $850M | $720M | $561M | $483M | |
| Retained Earnings | $-498M | $-491M | $-402M | $-297M | |
| AOCI | $543.0K | $-151.0K | $-24.0K | $-1M | |
| Stockholders' Equity | $352M | $229M | $160M | $185M | |
| Liabilities + Equity | $418M | $272M | $228M | $256M | |
| Shares Outstanding | 58,921,999 | 54,032,826 | 45,918,233 | 39,439,575 |
Flux de trésorerie 8
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $32M | $27M | $25M | $23M | |
| Operating Cash Flow | $46M | $-87M | $-81M | $-32M | |
| CapEx | $670.0K | $203.0K | $2M | $4M | |
| Investing Cash Flow | $-187M | $-107M | $106M | $-46M | |
| Financing Cash Flow | $97M | $131M | $53M | $46M | |
| Net Change in Cash | $-44M | $-63M | $78M | $-31M | |
| Taxes Paid | $573.0K | · | · | · | |
| Free Cash Flow | $45M | $-87M | $-83M | $-36M |
Rentabilité 5
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -11.2% | -277.3% | -1307.2% | -841.2% | |
| Net Margin | -3.7% | -243.4% | -1192.5% | -814.7% | |
| EBITDA Margin | -11.2% | -277.3% | -1307.2% | -841.2% | |
| ROA | -2.0% | -35.6% | -43.2% | -40.8% | |
| ROE | -2.0% | -38.6% | -63.0% | -52.0% |
Liquidité et Solvabilité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 5.3 | 5.8 | 7.0 | 7.8 | |
| Quick Ratio | 1.6 | 3.2 | 6.2 | 3.6 | |
| Interest Coverage | -2287.8 | -3898.9 | · | · |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.1 | 0.0 | 0.1 | |
| Receivables Turnover | 48.5 | · | · | · |
Taux de croissance 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 404.5% | 316.3% | -29.2% | · | |
| Revenue CAGR 3Y | 145.9% | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $184M | $37M | $9M | $12M | |
| Net Income TTM | $-7M | $-89M | $-105M | $-101M | |
| Market Cap | $1.87B | $596M | $242M | $364M | |
| P/E | -264.5 | -6.7 | -2.2 | -3.5 | |
| P/S | 10.1 | 16.3 | 27.5 | 29.3 | |
| P/B | 5.3 | 2.6 | 1.5 | 2.0 | |
| P / Tangible Book | 5.3 | 2.6 | 1.5 | 2.0 | |
| P / Cash Flow | 41.0 | -6.9 | -3.0 | -11.4 | |
| P / FCF | 41.6 | -6.8 | -2.9 | -10.2 | |
| Earnings Yield | -0.38% | -15.0% | -45.2% | -28.2% |
Compte de résultat 16
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6M | $1M | $11M | $14M | $159M | $23M | $5M | $5M | $4M | $3M | $3M | $-2M | $5M | $3M | $3M | $3M | |
| R&D Expense | $40M | $42M | $38M | $26M | $33M | $23M | $22M | $21M | $22M | $22M | $20M | $21M | $20M | $21M | $20M | $18M | |
| SG&A Expense | $20M | $21M | $16M | $15M | $15M | $13M | $13M | $13M | $10M | $11M | $10M | $10M | $10M | $9M | $10M | $10M | |
| Operating Expenses | $60M | $63M | $54M | $41M | $47M | $36M | $35M | $34M | $33M | $32M | $31M | $31M | $30M | $30M | $30M | $28M | |
| Operating Income | $-53M | $-61M | $-43M | $-27M | $111M | $-14M | $-30M | $-29M | $-28M | $-30M | $-27M | $-33M | $-25M | $-27M | $-27M | $-25M | |
| Interest Expense | $23.0K | $2.0K | $3.0K | $3.0K | $1.0K | $-1.0K | $0 | $5.0K | $22.0K | · | · | · | · | · | · | · | |
| Interest Income | $3M | $4M | $3M | $4M | $3M | $3M | $4M | $4M | $2M | · | · | · | · | · | · | · | |
| Other Non-op | $18.0K | $-110.0K | $3.0K | $28.0K | $28.0K | $201.0K | $28.0K | $-48.0K | $-428.0K | $42.0K | $41.0K | $41.0K | $42.0K | $41.0K | $42.0K | $42.0K | |
| Pretax Income | $-50M | · | $-40M | $-23M | $114M | · | $-26M | $-26M | $-26M | · | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $-1M | $0 | $1M | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | |
| Net Income | $-50M | $-58M | $-38M | $-23M | $113M | $-10M | $-26M | $-26M | $-26M | $-27M | $-25M | $-31M | $-23M | $-26M | $-26M | $-25M | |
| EPS (Basic) | $-0.79 | $-1.02 | $-0.65 | $-0.40 | $1.95 | $-0.15 | $-0.47 | $-0.46 | $-0.57 | $-0.61 | $-0.55 | $-0.69 | $-0.53 | $-0.65 | $-0.66 | $-0.63 | |
| EPS (Diluted) | $-0.79 | $-0.97 | $-0.65 | $-0.40 | $1.90 | $-0.15 | $-0.47 | $-0.46 | $-0.57 | $-0.61 | $-0.55 | $-0.69 | $-0.53 | $-0.65 | $-0.66 | $-0.63 | |
| Shares (Basic) | 63,063,507 | -115,609,022 | 58,611,677 | 58,353,855 | 57,862,674 | -104,345,028 | 56,341,074 | 55,765,948 | 46,246,889 | -86,996,093 | 44,266,017 | 44,188,464 | 42,536,474 | -77,229,527 | 39,420,310 | 39,258,358 | |
| Shares (Diluted) | 63,063,507 | -117,144,948 | 58,611,677 | 58,353,855 | 59,398,600 | -104,345,028 | 56,341,074 | 55,765,948 | 46,246,889 | -86,996,093 | 44,266,017 | 44,188,464 | 42,536,474 | -77,229,527 | 39,420,310 | 39,258,358 | |
| EBITDA | $-53M | · | $-43M | $-27M | $111M | · | $-30M | $-29M | $-28M | · | $-27M | $-33M | $-25M | · | $-27M | $-25M |
Bilan 21
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $156M | $84M | $83M | $101M | $275M | $128M | $150M | $193M | $179M | $191M | $190M | $192M | $190M | $114M | $113M | $68M | |
| Receivables | $4M | $6M | $9M | · | · | $2M | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $10M | $9M | $8M | $14M | $13M | $11M | $10M | $10M | $11M | $11M | $11M | $11M | $10M | $11M | $13M | $13M | |
| Other Current Assets | $7M | $4M | $6M | $7M | $5M | $2M | $4M | $4M | $4M | $3M | $4M | $4M | $6M | $3M | · | · | |
| Current Assets | $367M | $306M | $272M | $270M | $376M | $233M | $254M | $297M | $193M | $215M | $230M | $246M | $270M | $244M | $265M | $289M | |
| PP&E (Net) | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $6M | $6M | $6M | $7M | $7M | $7M | $6M | |
| PP&E (Gross) | · | $13M | · | · | · | $13M | · | · | · | $12M | · | · | · | $11M | · | · | |
| Accum. Depreciation | · | $10M | · | · | · | $9M | · | · | · | $7M | · | · | · | $4M | · | · | |
| Total Assets | $443M | $418M | $360M | $385M | $407M | $272M | $293M | $308M | $205M | $228M | $240M | $257M | $282M | $256M | $278M | $301M | |
| Accounts Payable | $7M | $5M | $6M | $4M | $2M | $2M | $2M | $4M | $2M | $2M | $3M | $2M | $4M | $766.0K | $2M | $4M | |
| Current Liabilities | $41M | $58M | $42M | $39M | $45M | $40M | $50M | $44M | $36M | $31M | $25M | $22M | $32M | $31M | $29M | $28M | |
| Capital Leases | $990.0K | $1M | $2M | $1M | $2M | $2M | $3M | $4M | $4M | $5M | $819.0K | $1M | $2M | $3M | $3M | $4M | |
| Other Non-current Liabilities | $991.0K | $1M | $2M | $1M | $2M | $2M | $3M | $4M | $4M | $5M | $959.0K | $2M | $2M | $3M | $4M | $4M | |
| Total Liabilities | $48M | $66M | $52M | $50M | $57M | $43M | $61M | $65M | $65M | $69M | $67M | $67M | $68M | $71M | $73M | $77M | |
| Common Stock | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $943M | $850M | $747M | $736M | $728M | $720M | $712M | $697M | $569M | $561M | $548M | $541M | $534M | $483M | $477M | $471M | |
| Retained Earnings | $-548M | $-498M | $-440M | $-401M | $-378M | $-491M | $-480M | $-454M | $-428M | $-402M | $-375M | $-350M | $-320M | $-297M | $-271M | $-245M | |
| AOCI | $-115.0K | $543.0K | $446.0K | $96.0K | $-104.0K | $-151.0K | $166.0K | $-15.0K | · | $-24.0K | $-147.0K | $-379.0K | $-598.0K | $-1M | $-2M | $-1M | |
| Stockholders' Equity | $395M | $352M | $308M | $335M | $350M | $229M | $232M | $243M | $140M | $160M | $173M | $190M | $214M | $185M | $204M | $224M | |
| Liabilities + Equity | $443M | $418M | $360M | $385M | $407M | $272M | $293M | $308M | $205M | $228M | $240M | $257M | $282M | $256M | $278M | $301M | |
| Shares Outstanding | 62,240,347 | 58,921,999 | 55,120,002 | 54,723,455 | 54,595,714 | 54,032,826 | 52,941,191 | 52,305,641 | 46,498,077 | 45,918,233 | 44,293,115 | 44,202,997 | 44,175,089 | 39,439,575 | 39,426,440 | 39,382,467 |
Flux de trésorerie 8
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $9M | $10M | $8M | $8M | $7M | $7M | $7M | $7M | $5M | $6M | $7M | $7M | $6M | $6M | $6M | $6M | |
| Operating Cash Flow | $-61M | $-30M | $-30M | $-25M | $132M | $-23M | $-22M | $-17M | $-25M | $-21M | $-17M | $-22M | $-21M | $-22M | $-22M | $-20M | |
| CapEx | $353.0K | $232.0K | $132.0K | $154.0K | $152.0K | $42.0K | $103.0K | $46.0K | $12.0K | $229.0K | $383.0K | $839.0K | $165.0K | $409.0K | $2M | $682.0K | |
| Investing Cash Flow | $51M | $-61M | $9M | $-148M | $14M | $819.0K | $-30M | $-88M | $10M | $15M | $15M | $23M | $53M | $22M | $67M | $146.0K | |
| Financing Cash Flow | $84M | $92M | $3M | $554.0K | $1M | $568.0K | $8M | $121M | $2M | $7M | $562.0K | $48.0K | $45M | $43.0K | $434.0K | $3M | |
| Net Change in Cash | $74M | $826.0K | $-18M | $-173M | $147M | $-22M | $-43M | $15M | $-13M | $1M | $-2M | $2M | $77M | $160.0K | $46M | $-16M | |
| Free Cash Flow | $-61M | · | · | · | $132M | · | · | · | $-25M | · | · | · | $-22M | · | · | · | |
| Levered FCF | $-61M | · | · | · | $132M | · | · | · | · | · | · | · | · | · | · | · |
Rentabilité 7
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -857.6% | · | -405.3% | -197.6% | 70.2% | · | -613.1% | -607.4% | -673.0% | · | -823.3% | 1340.7% | -479.2% | · | -934.5% | -781.1% | |
| Net Margin | -802.8% | · | -360.7% | -170.0% | 71.2% | · | -540.0% | -531.9% | -625.6% | · | -741.9% | 1235.5% | -437.6% | · | -898.8% | -763.0% | |
| Pretax Margin | -802.8% | · | -372.7% | -170.0% | 72.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -857.6% | · | -405.3% | -197.6% | 70.2% | · | -613.1% | -607.4% | -673.0% | · | -823.3% | 1340.7% | -479.2% | · | -934.5% | -781.1% | |
| ROA | -11.8% | · | -11.7% | -6.8% | 36.9% | · | -9.9% | -9.1% | -10.8% | · | -9.5% | -11.0% | -7.5% | · | -9.8% | -8.7% | |
| ROE | -13.4% | · | -14.2% | -8.1% | 46.0% | · | -13.1% | -11.9% | -14.9% | · | -13.0% | -14.8% | -9.9% | · | -11.8% | -10.3% | |
| ROIC | -13.5% | · | -13.5% | -8.2% | 31.4% | · | · | · | · | · | · | · | · | · | · | · |
Liquidité et Solvabilité 3
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.0 | · | 6.5 | 7.0 | 8.4 | · | 5.1 | 6.7 | 5.4 | · | 9.1 | 11.3 | 8.6 | · | 9.2 | 10.5 | |
| Quick Ratio | 3.9 | · | 2.2 | 2.6 | 6.2 | · | 3.0 | 4.3 | 5.0 | · | 7.5 | 8.8 | 6.0 | · | 3.9 | 2.5 | |
| Interest Coverage | -2322.5 | · | -14363.7 | -9100.0 | 111240.0 | · | · | · | · | · | · | · | · | · | · | · |
Efficacité 2
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.5 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | -0.0 | 0.0 | · | 0.0 | 0.0 | |
| Receivables Turnover | 2.8 | · | 2.3 | · | · | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $189M | · | $188M | $182M | $173M | · | $17M | $10M | $10M | · | $9M | $9M | $14M | · | · | · | |
| Net Income TTM | $1M | · | $25M | $37M | $34M | · | $-103M | $-107M | $-104M | · | $-104M | $-104M | $-98M | · | $-98M | $-94M | |
| Market Cap | $2.03B | · | $1.30B | $621M | $363M | · | $651M | $707M | $628M | · | $175M | $470M | $368M | · | $506M | $520M | |
| P/E | 542.7 | · | 61.8 | 19.9 | 16.6 | · | -6.0 | -6.0 | -5.8 | · | -1.6 | -4.2 | -3.4 | · | -5.0 | -5.3 | |
| P/S | 10.7 | · | 6.9 | 3.4 | 2.1 | · | 37.7 | 71.6 | 61.6 | · | 19.6 | 53.4 | 25.8 | · | · | · | |
| P/B | 5.1 | · | 4.2 | 1.9 | 1.0 | · | 2.8 | 2.9 | 4.5 | · | 1.0 | 2.5 | 1.7 | · | 2.5 | 2.3 | |
| P / Tangible Book | 5.1 | · | 4.2 | 1.9 | 1.0 | · | 2.8 | 2.9 | 4.5 | · | 1.0 | 2.5 | 1.7 | · | 2.5 | 2.3 | |
| P / Cash Flow | -33.5 | · | · | · | 2.8 | · | · | · | -25.6 | · | · | · | -17.2 | · | · | · | |
| P / FCF | -33.3 | · | · | · | 2.8 | · | · | · | -25.5 | · | · | · | -17.1 | · | · | · | |
| Earnings Yield | 0.18% | · | 1.6% | 5.0% | 6.0% | · | -16.7% | -16.8% | -17.3% | · | -61.7% | -23.6% | -29.8% | · | -19.9% | -18.9% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $184M | $37M | $9M | $12M | — |
| Marge d'exploitation % | -11.2% | -277.3% | -1307.2% | -841.2% | — |
| Résultat net | $-7M | $-89M | $-105M | $-101M | $-86M |
| BPA dilué | $-0.12 | $-1.65 | $-2.38 | $-2.60 | $-2.34 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 5.3 | 5.8 | 7.0 | 7.8 | 13.4 |
| Ratio de liquidité réduite | 1.6 | 3.2 | 6.2 | 3.6 | 8.5 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $45M | $-87M | $-83M | $-36M | $-68M |
Dernières actualités Actualités récentes mentionnant cette entreprise
Signaux de trading Signaux d'achat/vente récents avec prix d'entrée et ratio risque/récompense
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.